Enoxaparin Generic Saga Continues: Momenta's Manufacturing Patent Invalid
Executive Summary
Jury verdict comes seven years after Momenta/Sandoz launched generic version of Lovenox; firms sought treble damages from Amphastar for willful infringement of manufacturing process patent.
You may also be interested in...
Amphastar Will Receive $59.9m In Momenta/Sandoz Settlement
The small generics company has talked about using the cash windfall from the expected settlement to fund clinical trials and possibly M&A.
Amphastar Poised To Receive $59.9m In Momenta/Sandoz Settlement
The small generic drug company has talked about using the cash windfall from the expected settlement to fund clinical trials and possibly M&A.
Liraglutide Generics May Need More Robust Analytical Methods After Novo Petition
ANDA pathway is not sufficient to review liraglutide generics because of molecule's complexity, Novo contends; Teva appears to be first filer for Victoza.